Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

TEMIS Acquires i3 Analytics

Published: Monday, July 01, 2013
Last Updated: Monday, July 01, 2013
Bookmark and Share
TEMIS complements leading-edge Luxid® semantic content enrichment platform with best-in-class data analytics and visualization capabilities.

TEMIS has announced that they have acquired the US-based i3 Analytics, a provider of advanced data analytics and visualization technologies, for an undisclosed amount.

Founded in 2011 and employing former NIH (National Institutes of Health) engineers, i3 Analytics provides the award-winning Biopharma Navigator, a Software-as-a-Service platform that charts the biopharma landscape based on Life Sciences open data.

Providing customers with tailor-made, relevant and intuitive visualization maps, the i3 Analytics' Biopharma Navigator enables Life Sciences professionals to work faster, provide critical information to their peers, and make fast and informed clinical, regulatory, and business decisions.

Awarded "Best Semantic Technology Solution" in January 2013 by the Software and Information Industry Association (SIIA) for its flagship platform Luxid®, TEMIS has developed an in-depth expertise serving the information extraction and semantic enrichment needs of a varied range of industries, including Defence, Publishing & Media, as well as Life Sciences, where demand for easy-to-use, intuitive visualization and analytics tools has been growing in step with the exponential growth of available unstructured content.

This acquisition reinforces TEMIS' commitment and capabilities to serving its customers by strengthening its product range with a complementary SaaS Analytics and Discovery offering and expanding its know-how with the integration of a team of former NIH engineers.

The acquisition will also enable TEMIS to accelerate its penetration into new application areas in Life Sciences.

"The acquisition of i3 Analytics demonstrates our commitment to the Life Sciences market", said Eric Brégand, CEO of TEMIS.

Brégand continued, "This transaction creates a best-in-class offering for our Life Sciences customers, based on the winning combination of deep computational linguistics expertise and leading-edge data visualization know-how. And we will be transposing the solution to other verticals where data analytics and information visualization are also becoming critical."

Moving forward, and with a focus on maintaining its commitment to simplicity and innovation, TEMIS will integrate the SaaS Biopharma Navigator into its Luxid® product line and make it available for other application segments.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More Than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Bloomberg BNA Selects TEMIS for Content Categorization and Enrichment
Leading legal publisher applying powerful Luxid® Content Enrichment solution to vast archive.
Wednesday, April 17, 2013
TEMIS Named SIIA CODiE Award Finalist for Best Semantic Technology Solution
Luxid® content enrichment platform earns prestigious content industry recognition.
Friday, January 11, 2013
TEMIS Selected to Provide Semantic Indexing and Content Enrichment Solution for Gannett
Gannett to deploy Luxid® across the company’s digital properties enterprise-wide, including USATODAY.COM.
Thursday, April 05, 2012
HCPro Partnering with TEMIS to Boost Power of New Compliance Products
HCPro adds TEMIS semantic content enrichment capabilities.
Monday, December 19, 2011
Temis Luxid® standardizes on UIMA
Temis’ UIMA support enables Organizations to integrate Luxid® into their Enterprise Content Management and Information Retrieval applications.
Thursday, October 05, 2006
Scientific News
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Manufactured Stem Cells to Advance Clinical Research
Clinical-grade cell line will enable development of new therapies and accelerate early-stage clinical research.
Dengue Virus Exposure May Amplify Zika Infection
Researchers at Imperial College London have found that the previous exposure to the dengue virus may increase the potency of Zika infection.
Gender Determination in Forensic Investigations
This study investigated the effectiveness of lip print analysis as a tool in gender determination.
Identifying Novel Types of Forensic Markers in Degraded DNA
Scientists have tried to verify the nucleosome protection hypothesis by discovering STRs within nucleosome core regions, using whole genome sequencing.
Proteins in Blood of Heart Disease Patients May Predict Adverse Events
Nine-protein test shown superior to conventional assessments of risk.
Higher Frequency of Huntington's Disease Mutations Discovered
University of Aberdeen study shows that the gene change that causes Huntington's disease is much more common than previously thought.
Starving Stem Cells May Enable Scientists To Build Better Blood Vessels
Researchers from the University of Illinois at Chicago College of Medicine have uncovered how changes in metabolism of human embryonic stem cells help coax them to mature into specific cell types — and may improve their function in engineered organs or tissues.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!